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The hygiene hypothesis postulates that reduced or altered microbial exposure early in life may lead to 
impaired immune maturation and, as consequence of this, development of allergic disorders. Thus, we 
examined if the infantile gut microbiota was related to the postnatal T cell development in vivo and if 
certain commensal gut bacteria were able to induce regulatory T cells (Tregs) in vitro. We also 
investigated if the proportion of Tregs was associated with allergic sensitization and allergic disease in the 
first 3 years of life. 
 
We showed that the gut commensal Staphylococcus aureus (S. aureus) could convert neonatal CD4
+
 T 
cells into FOXP3
+
CD25
+
CD127
low
 Tregs in vitro and that certain culture conditions were required for this 
conversion. Depletion of pre-existing Tregs before stimulation with S. aureus resulted in activated 
CD25
+
CD127
low
 T cells that increased proliferation of CD4
+
 responder T cells. In contrast, naive CD4
+
 T 
cells stimulated in the presence of pre-existing Tregs induced suppressive FOXP3
+
CD25
+
CD127
low
 Tregs. 
Finally, blocking programmed cell death ligand-1 (PD-L1) expressed on antigen presenting cells during 
stimulation with S. aureus, reduced or completely inhibited the induction of FOXP3
+
CD25
+
CD127
low
       
T cells. 
 
In the prospective FARMFLORA birth-cohort study, we found that children with an early gut microbiota 
including bifidobacteria and Escherichia coli (E. coli) had mononuclear cells with higher capacity to 
produce proinflammatory and Th2-related cytokines in response to phytohaemagglutinin (PHA) than 
children not colonized by these bacteria. In contrast, early colonization by S. aureus and enterococci was 
inversely related with the PHA-induced cytokine responses. The early bacterial gut colonization pattern 
was not associated with the proportion of putative FOXP3
+
CD25
high
 Tregs within the circulating CD4
+
 T 
cell population during early childhood. However, high proportions of FOXP3
+
CD25
high
 cells of the CD4
+
 
T cell population in early infancy were inversely related to the capacity of mononuclear cells to produce 
cytokines in response to PHA as well as to the proportions of CD45RO
+
 of CD4
+
 T cells later in 
childhood. Moreover, children who were sensitized at 18 and 36 months of age had higher proportions of 
putative FOXP3
+
CD25
high
 Tregs at birth and 3 days of life than children who remained non-sensitized. 
Allergic disease, on the other hand was not associated with the proportion of putative FOXP3
+
CD25
high
 
Tregs. 
 
In conclusion, these results indicate that S. aureus has an ability to convert naïve neonatal CD4
+
 T cells 
into FOXP3
+
CD25
+
CD127
low
 regulatory T cells in vitro, a process which is dependent on the presence of 
both thymic derived Tregs and of APCs that express PD-L1. However, the early bacterial gut colonization 
pattern was not related to the proportion of putative FOXP3
+
CD25
high
 Tregs within the circulating CD4
+
 T 
cell population in children during the first 3 years of life. Furthermore, as infants who were sensitized had 
higher proportion of FOXP3
+
CD25
high
 within the CD4
+
 T cell population early in life compared to healthy 
children, higher proportions of Tregs early in life do not seem to be protective against atopic disorders. 
Thus, it is possible that high proportions of putative FOXP3
+
CD25
high
 Tregs within the CD4
+
 T cell 
population early in infancy may modulate the effector T cell development in a way that could predispose 
to allergic sensitization. However, early gut colonization with a gut microbiota including bifidobacteria 
and E. coli might instead enhance the effector T cell development. 
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